Next Article in Journal
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro
Next Article in Special Issue
Lamivudine and Emtricitabine Dosing Proposal for Children with HIV and Chronic Kidney Disease, Supported by Physiologically Based Pharmacokinetic Modelling
Previous Article in Journal
Design, Synthesis, Characterization, and Evaluation of the Anti-HT-29 Colorectal Cell Line Activity of Novel 8-Oxyquinolinate-Platinum(II)-Loaded Nanostructured Lipid Carriers Targeted with Riboflavin
Previous Article in Special Issue
Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(3), 1022; https://doi.org/10.3390/pharmaceutics15031022
Action Date Notes Link
article xml file uploaded 22 March 2023 11:19 CET Original file -
article xml uploaded. 22 March 2023 11:19 CET Update https://www.mdpi.com/1999-4923/15/3/1022/xml
article pdf uploaded. 22 March 2023 11:19 CET Version of Record https://www.mdpi.com/1999-4923/15/3/1022/pdf
article html file updated 22 March 2023 11:20 CET Original file -
article html file updated 6 April 2023 21:38 CEST Update https://www.mdpi.com/1999-4923/15/3/1022/html
Back to TopTop